Skip to main content
. 2021 Aug 27;39(12):1579–1588. doi: 10.1002/stem.3446

FIGURE 1.

FIGURE 1

Analysis of the preclinical literature administering cell therapy to animal models of cardiac injury. A, The cumulative number and number per year of preclinical papers that administered cell therapy for heart failure. B, Breakdown of study proportion in terms of species used, delivery method and cell type administered. ADC, adipose derived cells; HDC, heart derived cells; MSC, mesenchymal stromal cells; PSC, pluripotent stem cells; SM, skeletal myoblasts